Search
for
Sort by
Research 931–960 of 1000+
- Hair Loss in Women
- Cyproterone acetate for hirsutism
- Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study
- Treatment of Hirsutism with a Gonadotropin-Releasing Hormone Agonist (Nafarelin)∗
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- Polycystic ovary syndrome and impact on health
- The clinical evaluation of hirsutism
- The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research
- Comorbidities in patients with alopecia areata
- The biochemical and phenotypic characterization of females homozygous for 5 alpha-reductase-2 deficiency.
- Therapeutic approach for metabolic disorders and infertility in women with PCOS
- ANTIANDROGEN TREATMENT OF POLYCYSTIC OVARY SYNDROME
- Polycystic Ovary Syndrome: Early Detection in the Adolescent
- Animal Models and the Developmental Origins of Polycystic Ovary Syndrome: Increasing Evidence for the Role of Androgens in Programming Reproductive and Metabolic Dysfunction
- Effective medical treatment for common baldness in women
- Non-classic congenital adrenal hyperplasia
- A guide to understanding polycystic ovary syndrome (PCOS)
- Spironolactone Therapy for Hirsutism in a Hyperandrogenic Woman
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- Pharmacotherapy of polycystic ovary syndrome - an update
- What every physician should know about polycystic ovary syndrome
- Regenerative Effect of Intraovarian Injection of Activated Autologous Platelet Rich Plasma: Serum Anti-Mullerian Hormone Levels Measured Among Poor-Prognosis In Vitro Fertilization Patients
- Identifying genes associated with the development of human polycystic ovary syndrome
- Premature Adrenarche
- Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women
- Polycystic ovary syndrome (PCOS)
- Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS)
- Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies
- Normal Pubertal Development in Daughters of Women With PCOS: A Controlled Study
- Polycystic ovary syndrome and infertility: an update